Efficacy and optimal dose of coenzyme Q10 supplementation on inflammation-related biomarkers: A GRADE-assessed systematic review and updated meta-analysis of randomized controlled trials.

This meta-analysis provides evidence for CoQ10 supplementation to reduce the level of inflammatory mediators in the general population and proposes that daily supplementation of 300-400 mg CoQ10 showed superior inhibition of inflammatory factors. This article is protected by copyright. All rights reserved.